Jeffery C. Baker - 31 Dec 2025 Form 5 Insider Report for AMES NATIONAL CORP (ATLO)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
5
Accepted by SEC
03 Feb 2026, 10:38:32 UTC
Prior SEC filing
23 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
John P Nelson by power of attorney

Key filing fact

Jeffery C. Baker filed Form 5 for AMES NATIONAL CORP (ATLO) on 03 Feb 2026.

Key facts

  • This page summarizes Jeffery C. Baker's Form 5 filing for AMES NATIONAL CORP (ATLO).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Feb 2026, 10:38.

Change

  • Previous filing in this sequence was filed on 23 Jun 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 5 disclosures.

View source filing

Reporting Owners (1)

CIK 0001917933 Primary reporting owner

Baker Jeffery C

Relationship
Director
Address
PO BOX 846, AMES
Signature
John P Nelson by power of attorney
Signature date
03 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATLO holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,579
Date
31 Dec 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The reporting person acquired 130 shares of ATLO common stock by dividend reinvestment. This information is based on a brokerage statement as of 12/31/2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .